Bone Cancer Treatment Market Global Trends 2019 – Size, Share, Trends, Top Companies, Significant Growth, Regional Analysis, Clinical Treatment Plan and Forecast by 2026

Global Bone Cancer Treatment Market Overview

Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer that develops in the skeletal system and destroys tissues. It can spread to distant organs such as lungs as well as it can lead to kidney cancer, prostate cancer, and breast cancer, which is also called secondary or metastatic bone cancer. Severe pain in bones it the major and primary symptom of bone cancer, which gets exaggerated with the time. Moreover, there is weight loss, fever, fatigue, muscle pain, bone crack, osteoporosis and osteopenia are also identified. Diagnosis of bone cancer involves understanding patient’s history and reasons causing pain. Besides, it can be diagnosed with computer tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), biopsy tests, and bone scan.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/93

Market Outlook

Global bone cancer treatment market can be classified on basis of type and treatment available for bone cancer

The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates from fast and uncontrollable growth of the bone and other related tissues. Types of primary bone cancer include osteosarcoma, chondrosarcoma, Ewing’s sarcoma, spindle cell sarcoma, and chordoma. Secondary bone cancer, also called metastatic bone cancer, arises due to spreading of cancer cells from different parts of body. It is also referred as metastatic bone cancer.

On the basis of therapies or treatments available, the global bone cancer treatment market is classified as radiation therapy, chemotherapy, cryosurgery, and surgical treatments. The major surgical practices used to treat bone cancer are limb amputation surgery and limb salvage surgery or limb sparing surgery. In radiation therapy, high energy X-rays or gamma-rays are used to destroy tumors. Chemotherapy is a pharmacological treatment that involves the use of anti-cancer drugs. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, and doxorubicin, among others. Cryosurgery is sometimes used in lieu of conventional surgery to kill tumors.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/93

Market Dynamics- Drivers

Increasing disease incidence creating favorable growth environment for Bone cancer treatment market

Growing occurrence of bone cancer cases is expected to drive growth of the global bone cancer market during the forecast period. Moreover, developed markets such as the U.S., U.K., Japan, Canada, Australia, Germany, and Spain have a robust healthcare infrastructure that provides patients with easy access to advanced healthcare facilities, which aids in early diagnosis of bone cancer. According to the American Cancer Society (ACS), approximately 3,300 new cases of bone cancer are expected to be diagnosed in 2016, resulting in around 1,490 deaths in the same year. Moreover, the ACS sates that in adults over 40% of primary bone cancers are chondrosarcomas. This is followed by osteosarcomas (28%), chordomas (10%), Ewing tumors (8%), and malignant fibrous histiocytoma/fibrosarcomas (4%). According to 2016 Cancer.Net estimates, 3,300 people of all ages in the U.S. would be diagnosed with primary bone cancer. New cases of bone cancer being diagnosed, which in turn, is expected to boost growth of the bone cancer treatment market in the U.S. Furthermore, rising incidence rate in Asia Pacific is expected to drive growth of the Asia Pacific bone cancer treatment market, owing to growing awareness among the populace.

Global players involved in the bone cancer treatment market

Major companies involved in the global bone cancer treatment market include Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.

In December 2016, Dr. Andre Roodt, a researcher at the University of Free State developed pain relieving drug for bone cancer patients. The drug is a liquid radioactive isotope that can detect cancer in the body. Innovation in treatment options would lead to better therapeutic outcomes.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/bone-cancer-treatment-market-93

Key developments in the bone cancer treatment market

Key players in the market are focused on gaining product approvals to expand their product portfolio. For instance, in August 2019, the U.S. FDA approved Celgene Corp’s Inrebic – a JAK inhibitor that blocks inflammation-causing Janus kinases enzymes— for bone marrow cancer treatment.

Moreover, major companies are adopting acquisition strategies to enhance their market share. For instance, in January 2019, Bristol-Myers Squibb announced to acquire Celgene Corp. in a US$ 74 billion deal.

Research and development of material that replicates human bone tissue is expected to offer lucrative opportunities for market players. For instance, in August 2019, a team of researchers from the Oregon Health and Science University published a research in the journal Nature Communications on the successful development of bone models replicating the key hallmarks of the bone cellular and extracellular microenvironment.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.